Introduction

Radiation toxins induce high toxicity reactions after exposure
Acute Radiation Disease (ARD) or Acute Radiation Syndromes (ARS) are defined as the collective toxic clinical states observed from the acute pathological processes in various doses of irradiated mammals; to include: systemic inflammatory response syndrome (SIRS), toxic multiple organ injury (TMOI), toxic multiple organ dysfunction syndromes (TMODS), and finally, toxic multiple organ failure (TMOF). [2, 10, 18, 21 ] Moderate and high doses of radiation induces necrosis of radiosensitive cells with the subsequent formation of radiation toxins and their induced acute inflammatory processes. Radiation necrosis is the most substantial and most severe form of radiation induced injury, and when widespread, has grave therapeutic implications [1, 3, 53] . Low doses of radiation exposure induces apoptosis (controlled, programmed death of radiosensitive cells) without significant levels of specific radiation-induced toxin formation and with only low levels of inflammatory response [17, 50, 62] . Studying the trigger mechanism for radiation-induced lymphocyte death, N.I. Sorokina used the results of numerous experiments to show that ionizing radiation induces changes in the antigen phenotype of immature thymocytes in mice. This has the same type of effect as chemical differentiation inductors and thymotropin, which indirectly attests to the specific modifying effect of ionizing radiation [97, 98] . B.D. Zhivotovskiy described radiation-induced apoptosis and demonstrated a quantitative association between the pyknotic changes in the cell nuclei of thymocytes and production of postradiation chromatin decay products. The enzyme responsible for the decomposition of chromatin in irradiated cells is Ca/Mg-dependent endonuclease. Areas of endonuclease SRD-1. RT Properties-In our experiments RT were isolated from central lymphatics of irradiated animals with different form of ARS and each of the RT possess differences in their radiomimetic properties. Cerebrovascular RT, and to a lesser extent, cardiovascular RT and gastrointestinal RT are neurotoxins. Hematopoetic RT -are strong hematotoxins. Hematopoetic RT can destroy red blood cells and initiate hemolysis, disrupt the blood clotting system and cause multi-organ degeneration and tissues damages. Hematopoietic RT possess important activity against pluripotent stem cells and blood marrow. Mineral residue 1.6 ± 0.07 0.9 ± 0.02 1.3 ± 0.04 3.4± 0.17 Table 2 . Biochemical composition of the toxic substances comprising Radiation Toxins.
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(SRD-Specific Radiation Determinants)
Material and methods
These studies were conducted at several different research institutions and laboratories listed as follows: Biotechnology Centre of Russian Academy of Science (North Osetia), Kazan All-Union Scientific Research Veterinary, Institute Belarussian Scientific and Research Institute for Radiobiology in Gomel, the St. Petersburg Veterinary Institute, the Advanced Medical Technology and Systems Inc., Ottawa-Richmond Hill, Ontario, Canada. The studies w e r e a p p r o v e d b y t h e A n i m a l C a r e a n d Use Committee for ethical animal research equivalent, at each institution. A largest volume of purified Radiation Toxin was prepared from larger mammalian irradiated animals. Subsequently the RT were characterized chemically and biologically. The experimental design of later studies compared relative toxicity, potential for development of acute radiation syndromes, and potential lethality after intravenous or intramuscular injections of SRD containing Radiation Toxins. More recent studies focused on the immunogenicity of small doses of SRDs and the potential to use these agents as vaccine countermeasures against radiation injury.
Experimental animals
These experiments have employed a wide variety of experimental and agricultural animals which include : Black motley cattle, 2. 
Radiation toxins description and isolation
The methods of immune depletion, affine immuno-lympho-plasmasorption, as well as direct extraction were used to refine and purify the specific Radiation Toxins from the central lymph of animals with Cerebrovascular, Cardiovascular , Gastrointestinal and Haemotopoietic forms of Radiation Toxins. [104, 110] Specific Radiation Determinants (SRD)-a group of Radiation Toxins isolated from lymph of irradiated mammals, had been divided to four important groups: 1.Cerebrovascular neurotoxic RT (SRD-1); 2.Cardiovascular RT(SRD-2); 3.Gastrointestinal RT (SRD-3); 4.Hematopoetic RT (SRD-4). The radiomimetic properties of Radiation Toxins preparations were evaluated on the basis of their capacity to induce radiobiological effects in radiation-naive animals after they were administered parenterally. Specific Cerebrovascular, Cardiovascular, Gastrointestinal and Hematopoietic Toxins (isolated from the lymph of animals irradiated at doses inducing Cerebral, Cardiovascular, Gastrointestinal and Haemotopoietic clinical forms of ARS) were dissolved in an isotonic solution of NaCl. The doses of preparations of Radiation Toxins which were administered was based on computation of the amount of SRD per unit volume of central lymph and absorbed dose of radiation. Radiation toxins of SRD group possess highly toxic properties and induce neuro-vascular and hematotoxic reactions in short time after administration. 
Results
SRD-1 Radiation Toxins induced injury of Central Nervous System and development of Acute Cerebrovascular form of Radiation Syndrome
The Cerebrovascular form of Radiation Toxins SRD-1) were administered to radiation naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg and 30 mg/kg. The injection of Cerebrovascular Radiation Toxins (SRD-1) to rats, rabbits, sheep produced bioeffects similar to the cerebrovascular form of ARS. (see Table 3 ) After parenteral administration, the animals experienced a short period of extreme agitation, followed by a deep coma, with alterations in breathing patterns and subsequently cardiovascular collapse. Death in 2-4 weeks.
Death in next 10 days.
Death in next 7-10 days.
Death in next 4-5 days.
Mixture of lower doses of toxins SRD 1+2+3+4
Cerebral edema, vomiting, hemorrhage, cardiac insufficiency.
Death in 4-5 hours
Death in 1-3 hours
Death in one hour
Death in one hour Table 3 . Radiation Toxins: Toxic properties of Radiation Toxins (SRD Group 1-4 ) after single injection and different forms of Acute Radiation Syndromes induced by each.
SRD-2 Radiation Toxins induced injury of the Cardiovascular System and development of symptoms mimicking the Acute Cardiovascular Radiation Syndrome
The Cardiovascular form of Radiation Toxins were administered to radiation naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg and 30 mg/kg. The injection of Cardiovascular (SRD-2) RT in toxic doses to rats, rabbits, sheep produced symptoms similar to the cardiovascular form of ARS. (see Table 3 ) In this experiment, the following symptoms were observed: a delayed, shorter duration and less extreme period of agitation than with SRD-1 RTs, followed by tachycardia, cardiac arrhythmias, tachypnea. Postmortem histopathological analysis revealed inflammatory changes in the cardiac muscle tissue. Case #2: Species in experiment-4 months old lamb. Radiation neurotoxin (SRD-2) in single dose 5 mg/kg of weight was administered intravenously. 14 hours after injection all the injected lambs were dead after with a clinical picture of cardiovascular shock: agitation, fever, agitation, tachycardia, arrhythmias, hypotension, hyperventilation, followed by lethargy, signs of coma and death. Post-mortal histopathology showed: Heart-damaged microvasculature, cardiac vasoconstriction , ischemic myocardium, contraction band necrosis, multiple cardiac hemorrhages. Kidneys: multiple petechies of haemorrhages, acute tubular necrosis and renal failure.
SRD-3 Radiation Toxins induced injury of the Gastrointestinal System and development of symptoms mimicking the Acute Gastrointestinal Radiation Syndrome
Administration of Gastrointestinal Radiation Toxins (SRD-3) were administered to radiation naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg and 30 mg/kg. Injection of SRD-3 in toxic doses to experimental animals produced different grades of the Gastrointestinal form of ARS. (see Table 3 ) Case #3: Experimental species: one year old sheep. After a single dose injection of 15 mg/kg of the SRD-3 Gastrointestinal radiation toxins (isolated from central lymph of animals with the gastrointestinal form of ARS) intravenously, the animals elicit the following: Clinical signsdecrease in appetite and increased peristalsis within hours after injection, followed by severe diarrhea, hematochezia, dehydration, and later followed by collapse over several days. Death occurred 5-10 days after toxin administration. Histopathology revealed-local vasoconstriction, damaged microvasculature, large vessel vasodilatation and hyperemia of the small bowel and colon. Hypertension was manifested approximately two hours after intravenous injection. Ultimately hypotension developed after days of vomiting, diarrhea and dehydration.
SRD-4 Radiation Toxins induced development of Acute Hematopoietic Acute Radiation Syndrome
The Hemotopoietic Radiation Toxins (SRD-4) were administered to radiation naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg and 30 mg/kg. Injection of SRD-4 to experimental animals resulted in erythrocytopenia, lymphocytopenia, leukocytopenia, and thrombocytopenia within days to weeks after injection. (see Table 3 ) The development of clinical features of the Acute Hemotopoietic Syndrome depended on the dose of SRD-4 Hematopoietic Radiation Toxins injected to radiation naïve animals. Autopsy of those animals that died showed acute or chronic hematotoxic reactions. The clinical signs were: short-term agitation within 2 hours after administration accompanied by a short-term leukocytosis which gave way to a progressive, profound leukopenia, mainly attributable to a decrease in the absolute number of lymphocytes, the minimal levels of which were measured between days 7 and 15 after injection. Total WBC was 1.2-1.6 1000/μl to 0.4-0.5 thousand/μl in sheep and 1.8-2.5 thousand/μl to 0.5-0.7 thousand/μl in cattle. The recovery of absolute and relative levels of leukocytes and lymphocytes was observed in some animals between days 30 and 60. Blood counts exhibited thrombocytopenia accompanied by progressive erythrocytopenia, which developed into profound anemia. An extensive blood analysis of the peripheral blood of the cattle showed that the processes induced by the SRD-4 injection and the processes occurring after irradiation were nearly identical. Analysis of the clinical reaction to SRD-4 administration, which was assessed on the basis of body temperature, and heart and respiration rate, established that all experimental animals showed reactions of the same type for all the tested doses and that sheep and horses were more sensitive to the administered preparation. Thus, in sheep, which received SRD-4 at the maximum dose tested, the body temperature increased by 1. 
Discussion
Radiation toxin SRD-1 (cerebrovascular radio-neurotoxin) activates pathophysiological processes and clinical symptoms / signs of central and peripheral nervous system injury with development of neurological and cognitive deficit, activation, followed by depression, of specific centers of the central nervous system, including autonomic nervous system pathways. Tables 4-7 Thus, if a researcher administers specific Radiation Toxins of one of the SRD groups to radiation naive animals, toxicity will be observed along a dose response curve, from doses as small as 0.1 mg/kg or 0.5 mg/kg up to the highest tested dose of 30 mg/kg. The observed toxicity will mimic the ARS syndrome specific to the exposure of the animals from which the SRDs were acquired. Thus the exogenously administered SRD initiates development of specific toxic reactions with symptoms of a specific ARS, hence the name-specific radiation determinant (SRD 1-4). The SRD-group molecules possess both toxic and antigenic properties. The molecular Koch's postulates, which are commonly applied to bacterial toxin pathogenecity, could also be applied to the biological effect produced by Radiation Toxins, and those postulates would mostly be satisfied to list RT as the causative agents [101, 106] .
Comparative analysis of bacterial toxins vs radiation toxins (see table 12)
We compared lethal toxicity and clinicopathological features and characteristics for Radiation Toxins and Bacterial Toxins. Pathogenic bacteria which colonize the intestine, can invade intestinal epithelial cells and lymphatics, and/or produce one or more toxins that are important etiologies of diarrheal disease [32, 42, 48, 57, 86, 87, 88] . Bacteria produce toxins and the mechanisms of action of bacterial toxins can be classified into three important groups (see Table 12 ) : 1. Toxins with intrinsic enzymatic activity -cytotoxic bacterial toxins. 2. Toxins that binds to receptors that stimulate the actions of second messengers -cytotonic bacterial toxins (e.g. botulinum or cholera toxins) . 3. Toxins that damage eukaryotic cell membranes -membranotoxic bacterial toxins. [32, 42, 48, 57, 86,] . We postulate that radiation toxins possess high enzymatic activity, damage cell membranes, and also activate cell receptors. We postulate that radiation toxin mechanisms of action depend on the toxin type and dose of radiation toxins. We postulate that Radiation Toxins could initiate two different types of cell death -programmed (apoptosis) or necrosis. [90, 91] . [12, 78, 79, 87] . Enterohemorrhagic Escherechia coli, EHEC contains a Shigella-like toxin. The Shiga toxin family contains Shiga-like toxin 1 (SLT-1) and Shiga-like toxin 2 (SLT-2). EHEC strains produce SLT -2 or combination SLT 1 and SLT 2 [12 ] . Shiga toxin is a cytotoxic for endothelial and epithelial cells including human colonic and ileal epithelial cells, and Blymphocytes [12] . Enteropathogenic Echerechia coli induce an important and distinctive histopathologic lesion in the intestine with destruction of microvilli -the classic histopathologic lesion -AE lesion [12 ] . There are two proteins responsible for development AE lesion -a 94-kDa protein and protein encoded by the eaeB gene. [12, 78, 79] . Table 4 . Bacterial Toxins and their mechanisms of action.
Escherichia Coli is an Enteric Gram-negative rods and their pathogenic strains contained the w i d e g r o u p o f t o x i n s w i t h d i f f e r e n t p r o p erties. Escherichia Coli contain endotoxin -
Enterotoxigenic Escherechia coli produce heat-stable (ST) and heat-labile enterotoxins (LT). STa is a cysteine-rich, 18-amino-acid peptide. ST is produced as a precursor that is cleaved by signal peptidase and translocated to the periplasm where is added three intra-molecular disulfide bonds crucial for toxin activity. A second proteolytic agent occurs extracellularly and produce biologically active and toxic ST [12,81,] . STa acts by binding to a protein intestinal epithelial receptor localized in brush border membrane. [12, 78] . E.coli heat-stable enterotoxin b is a 71-amino-acid precursor protein secreted extracellularly and proteolytically processed to a toxic form as a 48-amino-acid protein [12, 79] . E. coli heatlabile enterotoxin I is closely related to CT, including its structure and enzymatic activity. [12] . Other Escherechia coli Toxins include Cytolethal distending toxin and Cytotoxic necrotizing factors [12, 78, 79 ] . Staphylococcus aureus produces serologically distinct protein exotoxins named A, B, C1, C3, D, E. All of these exotoxins are small proteins (24-30 kDa) with important biological activities. All seven toxins stimulate local receptors in upper intestinal tracts [12, 86] . Staphylococcal enterotoxins are likely playing an important role in cytokine production and are most potent T-cell receptor activators and inducers of lymphocyte proliferation. This class of toxins could be classified as "superantigens", as well as the toxins produced by Streptococcus spp. and Clostridium perfringens. Superantigens presented directly to the T-
Clinical symptoms induced by Bacterial Superantigene
Clinical symptoms induced by radiation toxins (SRD group) and by irradiation. cell receptors by cells containing major histocompatability complex class II molecules, without processing by antigen-presenting cells [32, 48, 86] . Superantigens (SAgs) are a class of antigens which cause non-specific activation of T-cells resulting in polyclonal T cell activation and massive cytokine release. The large number of activated T-cells secrete large amounts of cytokines (the most important of which is TNF-alpha). [32, 86] . SAg stimulation of antigen presenting cells and T-cells elicits a response that is mainly inflammatory, focused on the action of TH-1 T-helper cells. Some of the major products are IL-1, IL-2, IL-6, TNF-, gamma interferon (IFN-), macrophage inflammatory protein 1 (MIP-1 ), MIP-1 , and also monocyte chemoattractant protein 1(MCP-1). Clinical symptoms / signs induced by bacterial Superantigenes include central and peripheral nervous system involvement (confusion, lethargy, vomiting, anorexia), involvement of the cardiovascular system with development of hypotenison, tachycardia and loss of sympathetic responsiveness. Bacterial Superantigenes activate toxic processes within the gastrointestinal system including acute vomiting and diarrhea. The important signs and clinical picture of bacterial superantigen hematotoxicity with development thrombocytopenia, leukopenia, lyphocytopenia and development of coagulopathy. Bacterial Superantigenes could activate injury of cutaneus system and diffuse rash, erythrodermia, desquamation. [32, 86] Radiation Toxins of SRD groups 1-4 can activate similar pathological processes, clinical picture and clinical signs as the bacterial superantigent toxicity and the three entities: 1) Acute Radiation Syndromes, 2) SRD RT-induced acute syndromes and Bacterial Toxin-induced sepstic reaction and toxicity can be compared. (see Table 5 ) (see table 6 ) Neurotoxic proteins can be isolated from various snake venoms. These proteins can potentially be a mix of neurotoxins ,which attack the nervous system; hemototoxins, which attack the circulatory system; plus cytotoxins, bungarotoxins and many other toxins that affect the body in different ways [6, 29, 49, 60, 61, 82, 83, 84, 85] . Almost all snake venom contains hyaluronidase, an enzyme that ensures rapid diffusion of the venom into the body of the bite-victim [82, 84] . Viper venoms from the Elapidae, Hydrophiidae, Atractaspididae, Viperidae and Colubridae families contain at least 25 separate classes of biologically active compounds, including enzymes and non-enzymatic molecules. Venom-neurotoxins activate different reactions with nerve synapse -presynaptic and postsynaptic action; and induce anticholinesterase-induced flaccid paralysis. Myotoxins from Venom could induce systemic skeletal muscle damage. Hemototoxins induce the development of severe microcirculatory injury, damage to vascular membranes, thrombosis or bleeding. [6, 82, 84] .
Central Nervous System involvement
Comparative analysis of toxins produced by venom toxins and radiation toxins
Radiation induced apoptosis and necrosis
Radiation induced Apoptosis and Necrosis as response of eukaryotic cells to influence of different types of radiation remain contraversion. Radiation induced cell death by triggering apoptosis pathways was described in many articles and supported by many scientists [11, 15, 17, 39, 51, 52, 53, 54, 55, 56; 57, 58, 59, 62, 63, 74, 75, 76, 78] . However some scientists and some institutions described processes developing in irradiated eukaryotic cells as necrosis [24;34;38] and some scientists describing a variety of complex mechanism and mentioned that radiation-induced cell death could developing under different mechanisms of pathogenesis which include and apoptosis and necrosis. [1, 34, 38, 43, 77 cysteine proteases, cleavage of PARP -poly (ADP-ribosyl) ation of nuclear proteins causes the inner mitochondrial membrane to become permeable for ions and other small molecules during both types of cell death-apoptosis and necrosis. Many mechanisms of cell necrosis and apoptosis are identical -for example, degradation of the Nuclear matrix is a Common Element during Radiation-Induced Apoptosis and Necrosis [1, 3, 11, 16, 24, 34, 38, 43, 53, 59, 78] . Data from different sources described that the differences between apoptosis and necrosis are much less numerous than previously studies suggested. [1, 78] . Joseph Dynlacht and his research group of scientists studied the outcome of human promyelocytic leukemia (HL60) cells irradiated with 10 or 50 Gy of X-rays and determined the mode of leukemic cell death. Different doses of X-rays induced different modes of cell death -cells irradiated with 10 Gy died by necrosis; cells irradiated with 50Gy died predominantly by apoptosis. [16] . The Cell Death Nomenclature Committee recommends the use of the appropriate diagnosis: apoptotic necrosis. [34] . Comparison and description of a cell's Necrosis and Apoptosis were provided by a group of scientists from different institutions and research groups [16, 34] . Apoptosis is described as a normally active, programmed process of cell death devoid of inflammation and toxins. [16, 34] . Necrosis possesses the characteristics of accidental or externally-induced cell death from the influence of different environmental factors and triggering development of inflammation and elaborating of toxins, release of proinflammatory active and toxic cellular contents into the intracellular and extracellular fluids and into the lymphatic systems and blood circulation [39, 55, 56, 62] . Caspases are important molecular mechanisms and central components of the apoptosis process [39, 50, 51, 52, 54, 58, 62, 74, 75, 77, 78] . However, apoptosis is the principal mechanisms by which cells are physiologically eliminated. During apoptotic death, cellular dissociation by caspases of cell compartments occur and cell compartments and molecules are packaged into apoptotic bodies to avoid immune activation. [24, 34, 78] . Necrosis was considered in past times as passive, uncontrolled and unorganized mechanism of cell death. At the present time necrosis is considered as an alternative form of programmed cell death whose activation induces important biological consequences including immune reactions and induced inflammation. [43, 51, 52, 67, 74, 75, 77] .
Inflammation induced by radiation
Radiation induces an important and aggressive inflammatory response in the irradiated tissues. [19, 20, 28, 30, 64, 65] . Acute Radiation Disease (ARD) or Acute Radiation Syndromes (ARS) were defined as a toxic, poisonous exposure with development of the acute pathological processes in irradiated animals: systemic inflammatory response syndrome (SIRS), toxic multiple organ injury (TMOI), toxic multiple organ dysfunction syndromes (TMOD), toxic multiple organ failure (TMOF) [2, 5, 18, 19, 21, 89, 90, 91] . Radiation-induced lung injury, radiation pneumonitis (RP), is a potentially fatal side-effect of thoracic radiation therapy [3, 4, 11, 15] . Radiation-induced thyroiditis: can occur after the use of radiation treatment and can result in lifelong hypothyroidism [18] . Irradiation of the liver with doses of 2,450-2,920 rads caused liver injury in 14 patients of 65 patients treated with radiation therapy [3, 28] . The clinical picture of radiation-induced hepatitis includes hepatomegaly, ascites, pleural effusion and alteration in liver function. Radiation injury of the central nervous system (CNS) has devastating and fatal clinical consequences and severely limits the dose that can be delivered in the radiotherapy of brain, head and neck, pulmonary and other tumors [19, 28, 30, 64, 65] . Hematopoetic system toxicity is a major limiting factor in the use of aggressive, combined modality therapy (chemotherapy + radiotherapy) in the treatment of malignant disease [14, 22, 40] . Permanent anemia and pancytopenia can be caused by the reduced capability for cellular proliferation due to the stem cells injury produced by radiation. [14, 69, 70, 72, 76] . Radiation induces an inflammatory response in the irradiated organs characterized by leukocyte infiltration and vascular permeability changes and vascular injury [90, 99] . Vascular injury is a key determinant of acute and chronic organ intoxication and dysfunction associated with irradiation of the different systems, including the gastrointestinal tract [9, 19, 20, 22,] . Radiotherapy is used in the treatment of pediatric brain tumors and is often associated with inflammation and behavior changing following irradiation-induced inflammation and injury in the developing brain [19, 20] . The consequences of irradiation microglial loss can be secondary to injury from pronounced inflammation [19, 20] . A prominent inflammatory response occurs following both ischemic and hemorrhagic forms of microcirculation disorders [19, 20] .
Roles of radiation toxins in developing of cellular structure radiation-induced injury
Radiation Toxins contained a group of biologically-active compounds which induce complicated but specific mechanisms of action with tissues and cellular damage. Radiation Toxins include a group of glycoproteins with high enzymatic activity against proteins, lipids, carbohydrates. Radiation Toxins contain a group of peptides with selective affinity to number of receptors and specific interactions with receptors of mammalian organisms. Toxins isolated from the irradiated mammals inhibit or activate a group of an ion channels, acetylcholine receptors, nicotinic receptors, membranes, coagulant/anticoagulant pathways. Our experiments involved injections to radiation-naïve animals of toxic doses of Radiation Toxins (SDR-group) which damaged endothelial cells of blood and lymphatic vessels, and injury to blood microcirculation in the brain, lungs, gastrointestinal tract, cardiovascular system. Administration (IV or IM) of the Haemotopoietic Radiation Toxins to radiationnaïve animals induced development of anemia with reduction of hemoglobin concentration, reduction of red blood cell count and reduction of white cell blood count. Hemotopoietic Radiation Toxins induced the development of hemolytic anaemia with accelerated destruction of mature red cells outside the bone marrow and destruction of pluripotent stem cells inside of the bone marrow. Radiation-induced hemolytic anemia occurred with intravascular and extravascular hemolysis. As a result of stem cell injury erythropenia, leukopenia, thropmbocytopenia developed within days after irradiation. However, the acute hemolytic extravascular and intravascular anemia with lysis of erythrocytes, developed after high doses of radiation.
Development of radiation countermeasures
There are many sources of oxidative stress in the lives of workers, whether they work in nuclear power facilities, on the front lines of international conflicts, or in the reaches of outer space. The exposure dose can vary substantially, but at minimum will accelerate the aging of their organ systems, and at worse could result in acute exposure syndromes that may be fatal. A common thread of the oxidative stress exposures is ROS-binding to critical cellular organelles and molecules, which can result in cellular dysfunction, mutation of nucleic acids, or even apoptotic cell death [107] . Currently there are no proven countermeasures for these exposures, aside from a clinical agent, Amifostine, (Etyhol™), which is used to reduce mucositis and other side effects from radiation therapy dose in cancer patients. The cytotoxic effects of different types of radiation may be the single most important clinicopathologic process by which oxidative damage is induced from reactive oxygen species and radiation toxicity induced by radiation toxins. Radiation toxins (SRDs) with high enzymatic activity and their ability to degraded a wide variety of extracellular proteins, lipids, carbohydrates and DNA molecules, induce damage of important intracellular compartments such as mitochondria, ion channels, DNA, as well as activating degradation of peptide bonds in important polypeptides in tissues and vascular endothelium. Yet the exact mechanism by which radiation toxins stimulate development of the ARS is poorly understood. Countermeasures against radiation toxicity can be developed both in oral formulas [109] and parenteral agents, e.g. Manganese SuperOxide Dismutase (MnSOD)-liposomes [108, 109] which can reduce radiation exposure-induced biological effects. The oral formulas consist of a combination of antioxidants and chemopreventive, anti-progression agents, which can reduce the likelihood of mild toxicity in acute low dose radiation exposures and tumor induction in chronic low dose exposures. The combination of oral formulas with higher dose reactive oxygen species scavengers, like Mn-SOD can improve survival in animals exposed to acute high dose total body irradiation [109] . In addition to these measures, active immunization by low, non-toxic doses of radiation toxins, (SRDs) can also be employed to reduce radiation toxicity. [104, 110] To be effective, SRD immunization must occur no less than 30 days before irradiation, and can be effective up to three years or more. Active immunization by radiation toxins can significantly improve the survival rate (up to 60%) versus placebo-controlled irradiated animals. Our studies attempt to show the potential ability of specific antibodies to neutralize radiation toxins and thus substantially reduce the effects on radiation-induced neuro-, vascular, gastrointestinal, and hematopoietic toxicity. [104, 110] Antiradiation antibodies prevent the radiation-induced cytolysis of selected groups of cells that are sensitive to radiation. Anti-radiation antibodies derived from different phases of the Acute Radiation Syndrome can compete with and thus prevent cytolysis mediated by cytotoxic lymphocytes. The therapeutic benefit of neutralization of SRD radiation toxins could make hemopoetic stem cell transplantation more effective. Antiradiation vaccine and IgG antibodies have shown activity in animals against several different types of radiation include gamma, heavy ions, and neutron irradiation. [104, 110] Preliminary and pilot studies in vitro, in animal models and recently in humans, are showing some promise for both efficacy and safety/tolerability. [108] [109] [110] With current unpredictability in the operation of nuclear power facilities, potential radio-biologic terrorist weapons, and human operations in extreme environments, it is important to develop countermeasures to radiation toxicity in order to protect the potentially exposed. The first step in developing these countermeasures is to fully understanding the mechanism of toxicity, as is attempted to be summarized in this chapter.
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